ES2191352T3 - Gel de dexametasona. - Google Patents

Gel de dexametasona.

Info

Publication number
ES2191352T3
ES2191352T3 ES98954349T ES98954349T ES2191352T3 ES 2191352 T3 ES2191352 T3 ES 2191352T3 ES 98954349 T ES98954349 T ES 98954349T ES 98954349 T ES98954349 T ES 98954349T ES 2191352 T3 ES2191352 T3 ES 2191352T3
Authority
ES
Spain
Prior art keywords
preparation
gel
dexametasone
viscosity
contained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98954349T
Other languages
English (en)
Inventor
Gunther Bellmann
Gudrun Claus-Herz
Christoph Kessler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Gerhard Mann Chem Pharm Fabrik GmbH
Original Assignee
Dr Gerhard Mann Chem Pharm Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Gerhard Mann Chem Pharm Fabrik GmbH filed Critical Dr Gerhard Mann Chem Pharm Fabrik GmbH
Application granted granted Critical
Publication of ES2191352T3 publication Critical patent/ES2191352T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Preparado oftalmológico con un contenido en dexametasona-dihidrogenofosfato-disodio como principio activo, así como, en caso dado, contenidos en aditivos habituales y agua, caracterizado porque el preparado contiene al menos una substancia gelificante compatible desde el punto de vista farmacológico en una cantidad suficiente para el ajuste de la viscosidad del preparado como gel, presentando el preparado un valor de pH por encima de 7, 3.
ES98954349T 1997-10-06 1998-10-05 Gel de dexametasona. Expired - Lifetime ES2191352T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19744113A DE19744113A1 (de) 1997-10-06 1997-10-06 Dexamethason-Gel

Publications (1)

Publication Number Publication Date
ES2191352T3 true ES2191352T3 (es) 2003-09-01

Family

ID=7844743

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98954349T Expired - Lifetime ES2191352T3 (es) 1997-10-06 1998-10-05 Gel de dexametasona.

Country Status (18)

Country Link
EP (1) EP1021192B1 (es)
JP (1) JP4156793B2 (es)
KR (1) KR100392481B1 (es)
CN (1) CN1142782C (es)
AR (1) AR017170A1 (es)
AT (1) ATE230601T1 (es)
BR (1) BR9812849A (es)
CA (1) CA2300806C (es)
DE (2) DE19744113A1 (es)
DK (1) DK1021192T3 (es)
ES (1) ES2191352T3 (es)
HK (1) HK1030748A1 (es)
HU (1) HU224986B1 (es)
IL (1) IL135001A0 (es)
MX (1) MXPA00003363A (es)
PL (1) PL189727B1 (es)
WO (1) WO1999017780A1 (es)
ZA (1) ZA989066B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808375A (en) 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
CN101190177B (zh) * 2006-11-24 2010-09-01 上海医药工业研究院 醋酸地塞米松局部成膜凝胶组合物及其应用
US20150190407A1 (en) * 2014-01-07 2015-07-09 Insite Vision Incorporated Methods for treatment of postoperative inflammation with reduced intraocular pressure

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2212392C3 (de) * 1972-03-15 1981-03-19 Avicon Inc., Fort Worth, Tex. Verwendung von mikrokristallinem Collagen zur Herstellung eines wäßrigen pharmazeutischen Mittels für die topische Anwendung am Auge
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
JPS63174924A (ja) * 1987-01-14 1988-07-19 Toko Yakuhin Kogyo Kk 軟膏基剤および軟膏剤
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
WO1995005803A1 (en) * 1993-08-20 1995-03-02 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
DE4404990C1 (de) * 1994-02-17 1995-05-04 Mann Gerhard Chem Pharm Fab Verfahren zur Herstellung eines sterilen Prednisolongels
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge

Also Published As

Publication number Publication date
EP1021192B1 (de) 2003-01-08
KR100392481B1 (ko) 2003-07-23
IL135001A0 (en) 2001-05-20
DE59806884D1 (en) 2003-02-13
DK1021192T3 (da) 2003-05-05
WO1999017780A1 (de) 1999-04-15
PL189727B1 (pl) 2005-09-30
ATE230601T1 (de) 2003-01-15
HU224986B1 (en) 2006-05-29
JP2001518510A (ja) 2001-10-16
CA2300806A1 (en) 1999-04-15
HK1030748A1 (en) 2001-05-18
AR017170A1 (es) 2001-08-22
DE19744113A1 (de) 1999-04-15
MXPA00003363A (es) 2007-12-07
HUP0003796A2 (hu) 2001-04-28
BR9812849A (pt) 2000-08-08
KR20010030939A (ko) 2001-04-16
HUP0003796A3 (en) 2001-05-28
PL341026A1 (en) 2001-03-26
ZA989066B (en) 1999-06-15
JP4156793B2 (ja) 2008-09-24
CN1142782C (zh) 2004-03-24
CA2300806C (en) 2004-02-03
CN1266369A (zh) 2000-09-13
WO1999017780A8 (de) 2000-01-27
EP1021192A1 (de) 2000-07-26

Similar Documents

Publication Publication Date Title
ES2151968T3 (es) Composiciones hemorroidales y metodo de utilizacion.
PL347671A1 (en) Compounds and compositions for delivering active agents
BG104265A (en) Pharmaceutical preparation containing clodronate as an active component and silication microcrystalline cellulose as a filler
DE69314096D1 (de) Mit Gel gefüllte Implantate
DE69013848D1 (de) Medizinische Einschraubelektrode mit Wirkstoffeluierung für die Implantation.
AU2274201A (en) Compounds and compositions for delivering active agents
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
MXPA02005173A (es) Composicion farmaceutica para el tratamiento de enfermedades asociadas con disminucion de masa osea.
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
UY25544A1 (es) Forma de dosificación de nefazodona
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
AR003435A1 (es) Una composicion farmaceutica oral organolepticamente aceptable de etodolac s (+)-
PH24392A (en) Pharmaceutical compositions for transdermal
ES2191352T3 (es) Gel de dexametasona.
WO2001041747A3 (de) Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
BR9812385A (pt) Formulações parasiticidas
MX9300406A (es) Derivados azabiciclicos procedimientos para su preparacion y composiciones que los contienen.
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.
EP0272393A3 (en) Pharmaceutical combination
ES2136141T3 (es) Implante dental.
AR022819A1 (es) Composiciones farmaceuticas para la administracion oral que comprenden un principio activo de la familia de las benzamidas, asi como por lo menos unpromotor de absorcion